In patients with metastatic non–clear cell renal cell carcinoma, the combination of cytoreductive nephrectomy and systemic therapy confers better survival, with respect to single treatments alone or no treatment.
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients
Rosiello G.;Briganti A.;
2021-01-01
Abstract
In patients with metastatic non–clear cell renal cell carcinoma, the combination of cytoreductive nephrectomy and systemic therapy confers better survival, with respect to single treatments alone or no treatment.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
